Cambridge Investment Research Advisors
FLNA

Cambridge Investment Research Advisors’s Filana Therapeutics FLNA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,719
Closed -$315K – 3578
2024
Q3 		$315K Buy
+10,719
New +$247K ﹤0.01% 2799
2024
Q1 		– Sell
-10,433
Closed -$235K – 3391
2023
Q4 		$235K Buy
10,433
+407
+4% +$8.6K ﹤0.01% 2796
2023
Q3 		$167K Sell
10,026
-1,940
-16% -$38.4K ﹤0.01% 2872
2023
Q2 		$293K Sell
11,966
-2,800
-19% -$67.4K ﹤0.01% 2548
2023
Q1 		$356K Buy
14,766
+1,308
+10% +$36.2K ﹤0.01% 2335
2022
Q4 		$398K Sell
13,458
-1,150
-8% -$41.3K ﹤0.01% 2206
2022
Q3 		$611K Buy
14,608
+806
+6% +$21.8K ﹤0.01% 1807
2022
Q2 		$388K Sell
13,802
-2,091
-13% -$52.8K ﹤0.01% 2154
2022
Q1 		$590K Sell
15,893
-144
-0.9% -$6.1K ﹤0.01% 1972
2021
Q4 		$701K Sell
16,037
-3,254
-17% -$171K ﹤0.01% 1831
2021
Q3 		$1.2M Buy
19,291
+10,593
+122% +$884K 0.01% 1396
2021
Q2 		$743K Buy
+8,698
New +$466K ﹤0.01% 1758

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Cambridge Investment Research Advisors's FLNA Position: Q4 2024 in Review

Cambridge Investment Research Advisors sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 10,719 shares — an estimated $315K sold.

Cambridge Investment Research Advisors first reported a position in FLNA in Q2 2021 and held it in 12 quarters. The position peaked at $1.2M in Q3 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Cambridge Investment Research Advisors reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,719 Filana Therapeutics shares in Q4 2024, an estimated $315K.
  • Cambridge Investment Research Advisors first reported a position in Filana Therapeutics in Q2 2021 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's Filana Therapeutics position peaked at $1.2M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.